Table S3 from The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies
Angela Su(Inserm), Alexandre Puissant(Délégation Paris 5), Marie‐Hélène Schlageter(Inserm), Raphaël Itzykson(Université Paris-Sud), Antoine Forget(Centre National de la Recherche Scientifique), Jean‐Baptiste Micol(Université Paris-Saclay), Gael Fortin(Inserm), Reinaldo Dal Bello(Centre National de la Recherche Scientifique), Kimberly Stegmaier(Broad Institute), Bryann Pardieu(Centre National de la Recherche Scientifique), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Gaetano Sodaro(Centre National de la Recherche Scientifique), Camille Lobry(Inserm), Gabriela Alexe(Broad Institute), Camille Vaganay(Inserm), Lina Benajiba(Inserm), Kris C. Wood(Duke University), Iléana Antony‐Debré(Inserm), Hava M. Golan(Ben-Gurion University of the Negev), Christopher F. Bassil(Duke University), Chaı̈ma Benaksas(Centre National de la Recherche Scientifique), Nina Fenouille(Délégation Paris 5), Justine Pasanisi(Centre National de la Recherche Scientifique), Giovanni Roti(University of Parma), Jun Qi(Georgia Institute of Technology), Kevin Lin(The University of Texas MD Anderson Cancer Center), Yana Pikman(Broad Institute), Thomas Cluzeau(Centre Hospitalier Universitaire de Nice), Justine C. Rutter(Duke University), Alain Pruvost(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Jean‐François Benoist(Hôpital Robert-Debré), Frank W. Ling, Hervé Dombret(Université Paris Cité)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k